These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 1126575

  • 1. Effect of neuraminidase on potency of inactivated influenza virus vaccines in mice.
    Reichert E, Mauler R.
    Dev Biol Stand; 1975; 28():319-23. PubMed ID: 1126575
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Protection of mice with recombinant influenza virus neuraminidase.
    Kilbourne ED, Pokorny BA, Johansson B, Brett I, Milev Y, Matthews JT.
    J Infect Dis; 2004 Feb 01; 189(3):459-61. PubMed ID: 14745703
    [Abstract] [Full Text] [Related]

  • 4. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.
    Epstein SL, Misplon JA, Lawson CM, Subbarao EK, Connors M, Murphy BR.
    J Immunol; 1993 Jun 15; 150(12):5484-93. PubMed ID: 8390536
    [Abstract] [Full Text] [Related]

  • 5. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit.
    Tamura S, Ito Y, Asanuma H, Hirabayashi Y, Suzuki Y, Nagamine T, Aizawa C, Kurata T.
    J Immunol; 1992 Aug 01; 149(3):981-8. PubMed ID: 1634780
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice.
    Qiu M, Fang F, Chen Y, Wang H, Chen Q, Chang H, Wang F, Wang H, Zhang R, Chen Z.
    Biochem Biophys Res Commun; 2006 May 19; 343(4):1124-31. PubMed ID: 16580631
    [Abstract] [Full Text] [Related]

  • 8. Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection.
    Sylte MJ, Hubby B, Suarez DL.
    Vaccine; 2007 May 10; 25(19):3763-72. PubMed ID: 17350145
    [Abstract] [Full Text] [Related]

  • 9. The role of antineuraminidase antibody in immunity to influenza virus infection.
    Schulman JL.
    Bull World Health Organ; 1969 May 10; 41(3):647-50. PubMed ID: 5309490
    [Abstract] [Full Text] [Related]

  • 10. Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation.
    Chen J, Fang F, Li X, Chang H, Chen Z.
    Vaccine; 2005 Jul 29; 23(34):4322-8. PubMed ID: 15925433
    [Abstract] [Full Text] [Related]

  • 11. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.
    Muhamed G, Greenbaum E, Zakay-Rones Z.
    Isr Med Assoc J; 2006 Mar 29; 8(3):155-8. PubMed ID: 16599048
    [Abstract] [Full Text] [Related]

  • 12. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, Gavrilov V, Massare M, Pushko P, Mytle N, Rowe T, Smith G, Ross TM.
    Vaccine; 2007 May 10; 25(19):3871-8. PubMed ID: 17337102
    [Abstract] [Full Text] [Related]

  • 13. [Long-term effect of oral immunization against influenza with a gamma ray-inactivated vaccine in mice].
    Noack K, Tischner H, Bräuniger S, Nordheim W, Pohl WD.
    Z Erkr Atmungsorgane; 1986 May 10; 166(3):286-9. PubMed ID: 3751154
    [Abstract] [Full Text] [Related]

  • 14. Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A/HK/1/68 (H3N2).
    Tang M, Harp JA, Wesley RD.
    Arch Virol; 2002 Nov 10; 147(11):2125-41. PubMed ID: 12417948
    [Abstract] [Full Text] [Related]

  • 15. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.
    Pediatrics; 2006 Sep 10; 118(3):e570-8. PubMed ID: 16950948
    [Abstract] [Full Text] [Related]

  • 16. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
    Altstein AD, Gitelman AK, Smirnov YA, Piskareva LM, Zakharova LG, Pashvykina GV, Shmarov MM, Zhirnov OP, Varich NP, Ilyinskii PO, Shneider AM.
    Arch Virol; 2006 May 10; 151(5):921-31. PubMed ID: 16292596
    [Abstract] [Full Text] [Related]

  • 17. The antibody response and immunity to challenge infection induced by whole, inactivated and tween-ether split influenza vaccines.
    Potter CW, Jennings R, Clark A.
    Dev Biol Stand; 2006 May 10; 39():323-8. PubMed ID: 604115
    [No Abstract] [Full Text] [Related]

  • 18. Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus.
    Wesley RD, Tang M, Lager KM.
    Vaccine; 2004 Sep 03; 22(25-26):3427-34. PubMed ID: 15308368
    [Abstract] [Full Text] [Related]

  • 19. Protective immunity afforded by inactivated H5N1 (NIBRG-14) vaccine requires antibodies against both hemagglutinin and neuraminidase in mice.
    Takahashi Y, Hasegawa H, Hara Y, Ato M, Ninomiya A, Takagi H, Odagiri T, Sata T, Tashiro M, Kobayashi K.
    J Infect Dis; 2009 Jun 01; 199(11):1629-37. PubMed ID: 19385735
    [Abstract] [Full Text] [Related]

  • 20. Cross-protection in mice after immunization with H2N2, H3N2, and Heq2Neq2 influenza virus strains.
    Anker WJ, Bakker AK, Masurel N.
    Infect Immun; 1978 Jul 01; 21(1):96-101. PubMed ID: 711325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.